Roswell Park Comprehensive Cancer Center Interventional Pulmonologist Nathaniel Ivanick, MD, Discusses Use of New Hybrid Metallic Y Stent to Treat a Severe Airway Obstruction Caused by a Malignant Lung Tumor
In this video, John M. Kane III, MD, FACS, chair of Surgical Oncology and Chief of the Melanoma/Sarcoma Service at Roswell Park, discusses some of the unique aspects of surgical oncology offered at the center and recent innovations in techniques
Chair of Thoracic Surgery at Roswell Park, Dr. Sai Yendamuri, shares insights into an exciting phase I trial evaluating the side effects of intraoperative photodynamic therapy with porfimer sodium in enhancing the response to immunotherapy ...
As the first to bring this technology to patients in New York State in July 2020, Dr. Ivanick has now performed more than 100 bronchoscopies using the platform, more than any other provider in New York State.
A phase 1/1b, open-label clinical trial underway at Roswell Park Comprehensive Cancer Center is taking a new approach to targeting KRAS G12C, the most common mutation in non-small cell lung cancer (NSCLC) and one that is sometimes present ...
As bans on menthol tobacco spread across the country and a potential ban looms at the federal level, researchers at Roswell Park Comprehensive Cancer Center and their colleagues at the University of Southern California (USC) are investigating ...
Dr. Grace Dy from Roswell Park reports updated CodeBreak 100 clinical trial results in Journal of Clinical Oncology
This site is intended for healthcare professionals